Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023.
Walgreens earlier this week opened its first Walgreens Specialty Pharmacy in the Omaha, Neb. market.
UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.
Diplomat Pharmacy on Wednesday announced the addition of Martino Luu to their senior leadership team as VP innovation and process improvement.
The RAND Corp. projected that the introduction of biosimilar drugs in the United States will reduce direct spending on biologics by $44.2 billion from 2014 to 2024.
Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim.
Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength.
The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.
he Food and Drug Administration last week announced approval for Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A.
From Oct. 27 through Nov. 1, 2014, more than 11,000 McKesson employees at more than 170 locations across the United States will participate in the 16th Community Days program.